The non-invasive ventilation mask and circuit market is driven by growing respiratory care needs, technological advancements, and increasing healthcare adoption.
The non-invasive ventilation mask and circuit market is expected to rise at a 9.3% CAGR between 2024 and 2034, according to Fact.MR. By 2034, the global market for these products is expected to reach US$ 8,860.0 million. According to Fact MR, a provider of market research and competitive intelligence, the global non-invasive ventilation mask and circuit market is rapidly growing and is expected to continue its growth trajectory in the coming years.
Ongoing awareness programs and educational initiatives aimed at both healthcare professionals and the general public may contribute to increased understanding of respiratory disorders and the benefits of non-invasive ventilation, consequently driving market growth. Favorable regulatory frameworks and support for the development and approval of non-invasive ventilation devices can facilitate market entry for new products and encourage innovation in the industry.
The overall increase in healthcare spending globally, especially in emerging markets, provides an opportunity for the expansion of the non-invasive ventilation market, with hospitals and healthcare facilities investing in advanced respiratory care solutions. Ongoing research and development efforts to enhance the performance, comfort, and usability of non-invasive ventilation devices can lead to the introduction of innovative products, fostering market growth.
The expansion of healthcare infrastructure in emerging markets and penetration into regions with previously limited access to advanced medical devices present opportunities for market expansion. Ongoing efforts to improve the design and comfort of non-invasive ventilation masks, along with features that enhance patient compliance, are expected to positively influence market growth. User-friendly and comfortable devices can contribute to better treatment adherence.
In 2024, the global non-invasive ventilation mask and circuit market is estimated to have a global market size of US$ 3,641.2 million.
The respiratory dysfunction segment is expected to dominate the market, with a market share of 44.5% in 2034.
The non-invasive ventilation masks category is expected to hold a market share of 67.4% in 2034.
China is predicted to acquire a 40.2% of the global market share in 2024.
East Asia is expected to account for a CAGR of 10.1% by 2034.
“Collaborations between key players in the medical device industry, as well as partnerships with research institutions and healthcare organizations, can lead to the development of more advanced and effective non-invasive ventilation products,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Non-invasive Ventilation Mask and Circuit Market:
Hamilton Medical, Inc.; Fisher & Paykel Healthcare Limited.; Air Liquid Medical Systems; Koninklijke Philips N.V.; ResMed Inc.; Dragerwerk AG & Co. KGaA; Armstrong Medical; Cardinal Health Inc.; Well Lead Medical Co. Ltd; Vyaire Medical; Intersurgical
Competitive Landscape
The non-invasive ventilation mask and circuit market is shaped by pricing, distribution channels, customer service, and regulatory compliance to gain a competitive edge. Adapting to market dynamics and staying abreast of technological advancements are essential for sustained success in this dynamic industry.
Company Portfolio
Air Liquide Medical Systems: It is part of the Air Liquide Group and focuses on providing medical gas systems, respiratory care solutions, and home healthcare services. The company offers a comprehensive range of non-invasive ventilation masks and circuits to support patients with respiratory conditions. The products are designed to provide reliable and efficient respiratory therapy.
Koninklijke Philips N.V.: Royal Philips, commonly known as Philips, is a Dutch multinational conglomerate with a diverse portfolio of products, including healthcare solutions. The company provides a comprehensive range of non-invasive ventilation masks and circuits as part of its respiratory care solutions.
Non-invasive Ventilation Mask and Circuit Market News:
Hamilton Medical Inc.: It is a Swiss manufacturer engaged in developing and producing medical equipment for respiratory and ventilation care. The company believes in strong R&D efforts and provides an integrated portfolio of ventilator solutions consisting of various masks and circuits, which provide convenience to patients along with improved lung support.
Fisher & Paykel Healthcare Limited: Fisher & Paykel Healthcare, a New Zealand-based company, is the prominent global supplier of respiratory care solutions and medical equipment. The organization is most famous for the wide variety of non-invasive ventilation masks and circuits it offers. The products are engineered to offer efficient respiratory assistance with a focus on patient comfort as well as ease of use.
Fact.MR, in its new offering, presents an unbiased analysis of the global non-invasive ventilation mask and circuit market, presenting historical analysis from 2019 to 2023 and forecast statistics for the period of 2024 to 2034.
The study reveals essential insights based on non-invasive ventilation mask and circuit market analysis by product type (non-invasive ventilation circuits, non-invasive ventilation masks), by application (anaesthesia, respiratory dysfunction, chronic obstructive pulmonary diseases, pneumonia, others), by end user (hospitals, ambulatory surgery centres, critical care, neonatal intensive care, homecare settings), and by region (North America, Latin America, Europe, East Asia, South Asia and Oceania, and Middle East & Africa).
Explore More Related Studies Published by Fact.MR Research:
The global market for non-invasive ventilators is forecasted to expand at a CAGR of 7.7% between 2024 and 2034 making the sales revenue reach from US$ 2.63 billion in 2024 to US$ 5.52 billion by the end of 2034.
The global respiratory protection equipment market is valued at US$ 19.09 billion in 2023. Global demand for respiratory protection equipment is predicted to increase at a steady CAGR of 6.5% and reach a market valuation of US$ 35.83 billion by the end of 2033.
The global anesthesia machine market size is expected to reach a valuation of US$ 14.1 billion in 2024. Projected to increase at a CAGR of 6%, worldwide sales of anesthesia machines are calculated to reach US$ 25.2 billion by 2034-end.
The global washable and reusable mask market is projected to generate revenue of US$ 2.7 billion in 2024 and climb to a value of US$ 5.77 billion by the end of 2034. The market has been forecasted to expand at 7.9% CAGR from 2024 to 2034.